DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia
Study Details
Study Description
Brief Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This laboratory study is looking at tissue samples from patients with T-cell acute lymphoblastic leukemia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
OBJECTIVES:
-
Identify the transcriptional signatures associated with the presence of NOTCH1 mutations in primary T-cell acute lymphoblastic leukemia (T-ALL) cells using oligonucleotide microarrays.
-
Characterize the global changes on gene expression resulting from the inactivation of NOTCH signaling in human T-ALL lymphoblasts.
OUTLINE: This is a multicenter study.
Frozen lymphoblast samples from patients with T-cell acute lymphoblastic leukemia (NOTCH1-mutated and wild type) are assessed for genetic expression profiles and mutations by microarray analysis and activated NOTCH1 protein by western blot analysis.
PROJECTED ACCRUAL: A total of 48 samples from patients will be accrued for this study.
Study Design
Outcome Measures
Primary Outcome Measures
- Transcriptional signatures associated with NOTCH1 mutations in T-cell acute lymphoblastic leukemia (T-ALL) cells [1 month]
Mutational analysis
- Global changes on gene expression resulting from inactivation of NOTCH signaling in T-ALL cells [1 month]
Gene expression
Eligibility Criteria
Criteria
DISEASE CHARACTERISTICS:
-
Confirmed diagnosis of T-cell acute lymphoblastic leukemia
-
Frozen lymphoblast samples available
-
NOTCH1-mutated or wild type sample available
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion Criteria:
- Not applicable
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- ECOG-ACRIN Cancer Research Group
- National Cancer Institute (NCI)
Investigators
- Study Chair: Adolfo A. Ferrando, MD, PhD, Herbert Irving Comprehensive Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- CDR0000529758
- ECOG-E2993T2
- R01CA129382